Literature DB >> 25586104

Nutritional supplements in age-related macular degeneration.

Doreen Schmidl1, Gerhard Garhöfer, Leopold Schmetterer.   

Abstract

Age-related macular degeneration (AMD) is the most frequent cause of blindness in the Western World. While with new therapies that are directed towards vascular endothelial growth factor (VEGF), a potentially efficient treatment option for the wet form of the disease has been introduced, a therapeutic regimen for dry AMD is still lacking. There is evidence from several studies that oral intake of supplements is beneficial in preventing progression of the disease. Several formulations of micronutrients are currently available. The present review focuses on the role of supplements in the treatment and prevention of AMD and sums up the current knowledge about the most frequently used micronutrients. In addition, regulatory issues are discussed, and future directions for the role of supplementation in AMD are highlighted.
© 2015 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Age-Related Eye Disease Study; age-related macular degeneration; lutein; reactive oxygen intermediates; supplementation; vitamins; zeaxanthin; zinc

Mesh:

Substances:

Year:  2015        PMID: 25586104     DOI: 10.1111/aos.12650

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  8 in total

Review 1.  Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.

Authors:  Jennifer R Evans; John G Lawrenson
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

2.  Metformin attenuated histopathological ocular deteriorations in a streptozotocin-induced hyperglycemic rat model.

Authors:  Nazmun Nahar; Suhaila Mohamed; Noordin Mohamed Mustapha; SengFong Lau; Nur Iliyani Mohd Ishak; Norshahira Solehah Umran
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-13       Impact factor: 3.000

3.  Perioperative topical ascorbic acid for the prevention of phacoemulsification-related corneal endothelial damage: Two case reports and review of literature.

Authors:  Chia-Yi Lee; Hung-Ta Chen; Yi-Jen Hsueh; Hung-Chi Chen; Chieh-Cheng Huang; Yaa-Jyuhn James Meir; Chao-Min Cheng; Wei-Chi Wu
Journal:  World J Clin Cases       Date:  2019-03-06       Impact factor: 1.337

4.  Comparison of Mouse and Human Retinal Pigment Epithelium Gene Expression Profiles: Potential Implications for Age-Related Macular Degeneration.

Authors:  Anna Bennis; Theo G M F Gorgels; Jacoline B Ten Brink; Peter J van der Spek; Koen Bossers; Vivi M Heine; Arthur A Bergen
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

Review 5.  Recent advances in the management and understanding of macular degeneration.

Authors:  Sepehr Bahadorani; Michael Singer
Journal:  F1000Res       Date:  2017-04-20

6.  Serum carotenoids and macular pigment optical density in patients with intestinal resections and healthy subjects: an exploratory study.

Authors:  Jane N Eriksen; August P Prahm; Mads Krüger Falk; Eva Arrigoni; Palle B Jeppesen; Michael Larsen; Lars O Dragsted
Journal:  J Nutr Sci       Date:  2018-02-05

Review 7.  The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut⁻Retina Axis.

Authors:  Emanuele Rinninella; Maria Cristina Mele; Nicolò Merendino; Marco Cintoni; Gaia Anselmi; Aldo Caporossi; Antonio Gasbarrini; Angelo Maria Minnella
Journal:  Nutrients       Date:  2018-11-05       Impact factor: 5.717

Review 8.  Age-Related Macular Degeneration: New Paradigms for Treatment and Management of AMD.

Authors:  Luis Fernando Hernández-Zimbrón; Ruben Zamora-Alvarado; Lenin Ochoa-De la Paz; Raul Velez-Montoya; Edgar Zenteno; Rosario Gulias-Cañizo; Hugo Quiroz-Mercado; Roberto Gonzalez-Salinas
Journal:  Oxid Med Cell Longev       Date:  2018-02-01       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.